Astec Lifesciences receives ratings action from ICRA

25 Jun 2022 , 10:43 AM

Astec Lifesciences announced that ICRA has reaffirmed/ assigned the long-term rating of ?[ICRA]AA-? (pronounced ICRA double A minus) and the short term rating of ?[ICRA]A1+? (pronounced ICRA A one plus) for the Rs. 839 crore (enhanced from Rs.574 crore) Fund Based and Non-Fund Based facilities of the Company. Further, ICRA has revised the outlook on the long-term rating from Stable to PositivePowered by Capital Market – Live News